95 related articles for article (PubMed ID: 3393140)
1. Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit.
Taylor EW; Nikam SS; Lambert G; Martin AR; Nelson DL
Mol Pharmacol; 1988 Jul; 34(1):42-53. PubMed ID: 3393140
[TBL] [Abstract][Full Text] [Related]
2. Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites.
Taylor EW; Nikam S; Weck B; Martin A; Nelson D
Life Sci; 1987 Oct; 41(16):1961-9. PubMed ID: 3657392
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional quantitative structure-activity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods.
Agarwal A; Pearson PP; Taylor EW; Li HB; Dahlgren T; Herslöf M; Yang Y; Lambert G; Nelson DL; Regan JW
J Med Chem; 1993 Dec; 36(25):4006-14. PubMed ID: 8258822
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes.
McKenna DJ; Repke DB; Lo L; Peroutka SJ
Neuropharmacology; 1990 Mar; 29(3):193-8. PubMed ID: 2139186
[TBL] [Abstract][Full Text] [Related]
5. 1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors.
Macor JE; Fox CB; Johnson C; Koe BK; Lebel LA; Zorn SH
J Med Chem; 1992 Oct; 35(20):3625-32. PubMed ID: 1433172
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat.
Tricklebank MD; Middlemiss DN; Neill J
Neuropharmacology; 1986 Aug; 25(8):877-86. PubMed ID: 3022180
[TBL] [Abstract][Full Text] [Related]
7. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
[TBL] [Abstract][Full Text] [Related]
8. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
9. Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles.
Perregaard J; Andersen K; Hyttel J; Sánchez C
J Med Chem; 1992 Dec; 35(26):4813-22. PubMed ID: 1336053
[TBL] [Abstract][Full Text] [Related]
10. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.
Lyon RA; Titeler M; Seggel MR; Glennon RA
Eur J Pharmacol; 1988 Jan; 145(3):291-7. PubMed ID: 3350047
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
Matsumoto I; Combs MR; Jones DJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
Cozzi NV; Daley PF
Bioorg Med Chem Lett; 2016 Feb; 26(3):959-964. PubMed ID: 26739781
[TBL] [Abstract][Full Text] [Related]
14. Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region.
Glennon RA; Chaurasia C; Titeler M
J Med Chem; 1990 Oct; 33(10):2777-84. PubMed ID: 2213830
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
Mattsson C; Svensson P; Boettcher H; Sonesson C
Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
[TBL] [Abstract][Full Text] [Related]
17. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors.
Street LJ; Baker R; Castro JL; Chambers MS; Guiblin AR; Hobbs SC; Matassa VG; Reeve AJ; Beer MS; Middlemiss DN
J Med Chem; 1993 May; 36(11):1529-38. PubMed ID: 8496922
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.
Battaglia G; De Souza EB
NIDA Res Monogr; 1989; 94():240-58. PubMed ID: 2514364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
